Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Yoshinaka Murai"'
Publikováno v:
Heliyon, Vol 6, Iss 12, Pp e05830- (2020)
The depression of evoked fast excitatory postsynaptic potentials (EPSPs) following superfusion with various concentrations (3 μM-5 mM) of ammonium chloride (NH4Cl) were investigated in rat hippocampal CA1 neurons. The amplitude of the evoked fast EP
Externí odkaz:
https://doaj.org/article/20ce8c7055bd4018b5b93b81953f8b51
Publikováno v:
Heliyon
Heliyon, Vol 6, Iss 12, Pp e05830-(2020)
Heliyon, Vol 6, Iss 12, Pp e05830-(2020)
The depression of evoked fast excitatory postsynaptic potentials (EPSPs) following superfusion with various concentrations (3 μM-5 mM) of ammonium chloride (NH4Cl) were investigated in rat hippocampal CA1 neurons. The amplitude of the evoked fast EP
Publikováno v:
Neuroscience Letters. 636:120-126
Oxygen and glucose deprivation (OGD) elicits a rapid and irreversible depolarization with a latency of ∼5 min in intracellular recordings of hippocampal CA1 neurons in rat slice preparations. In the present study, we examined the role of cathepsin
Autor:
Munetake Yoshitomi, Yoshinaka Murai, Nobuyuki Takeshige, Motohiro Morioka, Salunya Tancharoen, Kiyoshi Kikuchi, Eiichiro Tanaka
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 7, Pp 13909-13930 (2013)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Edaravone was originally developed as a potent free radical scavenger, and has been widely used to treat acute ischemic stroke in Japan since 2001. Free radicals play an important role in the pathogenesis of a variety of diseases, such as cardiovascu
Autor:
Eiichiro Tanaka, Naoki Miura, Ko-ichi Kawahara, Paul A. Lapchak, Motohiro Morioka, Yoshinaka Murai, Kiyoshi Kikuchi
Publikováno v:
Biomedical Reports. 1:7-12
Acute ischemic stroke (AIS) is a major cause of morbidity and mortality in the aging population worldwide. Alteplase, a recombinant tissue plasminogen activator, is the only Food and Drug Administration-approved thrombolytic agent for the treatment o
Publikováno v:
International Journal of Molecular Sciences, Vol 13, Iss 6, Pp 7739-7761 (2012)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Stroke is an enormous public health problem with an imperative need for more effective therapies. In therapies for ischemic stroke, tissue plasminogen activators, antiplatelet agents and anticoagulants are used mainly for their antithrombotic effects
Autor:
Tomoyuki Takahashi, Toyojiro Matsuishi, Ken-ichiro Kosai, Yasunori Okabe, Eiichiro Tanaka, Yoshinaka Murai, Akira Kusaga, Hideho Higashi, Chiaki Mitsumasu
Publikováno v:
Brain Research. 1360:17-27
Mutations in methyl-CpG-binding protein 2 (MeCP2) gene cause the neurodevelopmental disorder Rett syndrome (RTT). Here, we describe a new experimental system that efficiently elucidates the role of MeCP2 in neural development. MeCP2-null and control
Autor:
Yoshinaka Murai, Hideho Higashi, Eiichiro Tanaka, Koki Shimoji, Yasunori Okabe, Aya Yamada, Tatsuhiko Kano, Toshiyuki Tobita
Publikováno v:
Neuroscience Research. 64:391-396
In humans, peripheral somatosensory information converges upon dorsal horn neurons in the spinal cord, which can be recorded from the dorsal epidural space as spinal cord potentials (SCPs) following segmental dorsal root stimulation (SS) employing ep
Publikováno v:
Biochemistry & Analytical Biochemistry.
In 2012, stroke was the second most common cause of death worldwide. One in 10 people with stroke die in hospital, and many more suffer ongoing disability, which highlights the need for more effective treatments.
Publikováno v:
Biochemistry & Analytical Biochemistry.
Alteplase (recombinant tissue plasminogen activator) is the only licensed drug for acute ischemic stroke (AIS) treatment, but only 3–5% of patients with AIS receive thrombolytic treatment using alteplase. Further breakthroughs are needed for thromb